NCT03804554View on ClinicalTrials.gov

A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab

CompletedOBSERVATIONAL
Enrollment

503

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

August 12, 2021

Study Completion Date

August 12, 2021

Conditions
Non-Small Cell Lung Cancer
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

3084

Local Institution, Heidelburg

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY